MMCAP International Inc. SPC reduced its holdings in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating) by 50.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 500,000 shares of the company's stock after selling 500,000 shares during the period. MMCAP International Inc. SPC's holdings in Intelligent Medicine Acquisition were worth $5,010,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of IQMD. Basso Capital Management L.P. bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $53,000. Woodline Partners LP bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $250,000. Sona Asset Management US LLC bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $299,000. Glazer Capital LLC bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $311,000. Finally, DLD Asset Management LP bought a new stake in Intelligent Medicine Acquisition in the first quarter valued at approximately $432,000. 55.04% of the stock is currently owned by institutional investors and hedge funds.

Intelligent Medicine Acquisition Stock Up 0.1 %

NASDAQ:IQMD traded up $0.01 during trading hours on Friday, hitting $10.22. The stock had a trading volume of 17,727 shares, compared to its average volume of 29,087. Intelligent Medicine Acquisition Corp. has a one year low of $9.86 and a one year high of $10.93. The business's 50 day moving average is $10.12 and its 200-day moving average is $10.06.

About Intelligent Medicine Acquisition

Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.

See Also

• Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMD)
• Institutions Are Buying Ambarella, Should You?
• Can ZIM Defy Broad Downturn In The Container Shipping Industry?
• Ford Revving Up Production Of EV Power Units At U.K. Plant
• Are the Short Sellers Still Right About Mullen Automotive stock?
• La-Z-Boy Reclines To More Comfortable Levels

Want to see what other hedge funds are holding IQMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating).

Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.